Drug interaction: Focusing on response surface models

Korean Journal of Anesthesiology

Volumn 58, Issue 5, 2010, Pages 421-434

  Lee, Soo Il ^a  

^a Dong A University   (South Korea)

Author keywords

AIC; Bliss independence; Drug interaction; Interaction index; Isobole; Loewe additivity; Response surface model

Indexed keywords

ROCURONIUM; VECURONIUM;

ADDITIVE INTERACTION; AKAIKE INFORMATION CRITERION; BLISS INDEPENDENCE; CARTER MODEL; DATA ANALYSIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; FIDLER MODEL; GRECO MODEL; KONG MODEL; LOEWE ADDITIVITY; MACHADO MODEL; MEDIAN EFFECT METHOD; METHODOLOGY; MINTO MODEL; PLUMMER MODEL; RESPONSE SURFACE METHOD; REVIEW;

EID: 77953336211     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.5.421     Document Type: Review

References (57)

1. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58: 621-81.
2. Hendrickx JF, Eger EI, 2nd, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg 2008; 107: 494-506.
3. Johnson KB, Syroid ND, Gupta DK, Manyam SC, Pace NL, Lapierre CD, et al. An evaluation of remifentanil-sevoflurane response surface models in patients emerging from anesthesia: model improvement using effect-site sevoflurane concentrations. Anesth Analg 2009. [Epub ahead of print].
4. Syroid ND, Johnson KB, Pace NL, Westenskow DR, Tyler D, Bruhschwein F, et al. Response surface model predictions of emergence and response to pain in the recovery room: an evaluation of patients emerging from an isoflurane and fentanyl anesthetic. Anesth Analg 2009. [Epub ahead of print].
5. Schumacher PM, Dossche J, Mortier EP, Luginbuehl M, Bouillon TW, Struys MM. Response surface modeling of the interaction between propofol and sevoflurane. Anesthesiology 2009; 111: 790-804.
6. Naguib M, Abdulatif M. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium. Br J Anaesth 1993; 71: 556-60.
7. Redai I, Richards KM, England AJ, Feldman SA. Interaction of decamethonium with hexamethonium or vecuronium in the rat: an isobolographic analysis. Anesth Analg 1995; 81: 768-72.
8. Paul M, Kindler CH, Fokt RM, Dipp NC, Yost CS. Isobolographic analysis of non-depolarising muscle relaxant interactions at their receptor site. Eur J Pharmacol 2002; 438: 35-43. (Pubitemid 34242917)
9. Berenbaum MC. What is synergy? Pharmacol Rev 1989; 41: 93-141.
10. Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 1995; 47: 331-85.
11. Bliss CI. The toxicity of poisons applied jointly. Ann Appl Biol 1939; 26: 585-615.
12. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 1953; 3: 285-90.
13. Chou TC. Drug combination studies and their synergy quantification using the chou-talalay method. Cancer Res 2010; 70: 440-6.
14. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol (Lond) 1910; 40: iv-vii.
15. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358-71.
16. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
17. Berenbaum MC. Criteria for analyzing interactions between biologically active agents. Adv Cancer Res 1981; 35: 269-335.
18. Fraser TR. An experimental research on the antagonism between the actions of physostigma and atropia. Proc R Soc Edingburgh 1870-1; 7: 506-11.
19. Fraser TR. The antagonism between the actions of active substances. Br Med J 1872; 2: 485-7.
20. Loewe S, Muischnek H. Effect of combinations: mathematical basis of problem. Arch Exp Pathol Pharmakol 1926; 114: 313-26.
21. Tallarida RJ. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 2006; 319: 1-7.
22. Grabovsky Y, Tallarida RJ. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 2004; 310: 981-6.
23. Tallarida RJ. Interactions between drugs and occupied receptors. Pharmacol Ther 2007; 113: 197-209.
24. Chou TC. Derivation and properties of michaelis-menten type and hill type equations for reference ligands. J Theor Biol 1976; 59: 253-76.
25. Chou TC. On the determination of availability of ligand binding sites in steady-state systems. J Theor Biol 1977; 65: 345-56.
26. Berenbaum MC. Synergy, additivism and antagonism in immuno-suppression. A critical review. Clin Exp Immunol 1977; 28: 1-18.
27. Goldoni M, Johansson C. A mathematical approach to study com bined effects of toxicants in vitro: evaluation of the bliss independence criterion and the loewe additivity model. Toxicol In Vitro 2007; 21: 759-69.
28. Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2006; 2: 458-66.
29. Martinez-Irujo JJ, Villahermosa ML, Mercapide J, Cabodevilla JF, Santiago E. Analysis of the combined effect of two linear inhibitors on a single enzyme. Biochem J 1998; 329: 689-98.
30. Lee JJ, Kong M, Ayers GD, Lotan R. Interaction index and different methods for determining drug interaction in combination therapy. J Biopharm Stat 2007; 17: 461-80.
31. Gessner PK. Isobolographic analysis of interactions: an update on applications and utility. Toxicology 1995; 105: 161-79.
32. Mead R, Pike DJ. A biometrics invited paper. A review of response surface methodology from a biometric viewpoint. Biometrics 1975; 31: 803-51.
33. Finney DJ. Probit Analysis. 3rd ed. Cambridge, UK, Cambridge University Press. 1971.
34. Greco WR, Park HS, Rustum YM. Application of a new approach for the quantitation of drug synergism to the combination of cisdiamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res 1990; 50: 5318-27.
35. Machado SG, Robinson GA. A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Stat Med 1994; 13: 2289-309.
36. Plummer JL, Short TG. Statistical modeling of the effects of drug combinations. J Pharmacol Methods 1990; 23: 297-309.
37. Carter WH, Gennings C, Staniswalis JG, Campbell ED, White KL. A statistical approach to the construction and analysis of isobolograms. Int J Toxicol 1988; 7: 963-73.
38. Kong M, Lee JJ. A generalized response surface model with varying relative potency for assessing drug interaction. Biometrics 2006; 62: 986-95.
39. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000; 92: 1603-16.
40. Fidler M, Kern SE. Flexible interaction model for complex interactions of multiple anesthetics. Anesthesiology 2006; 105: 286-96. (Pubitemid 44148173)
41. Hewlett PS. Measurement of the potencies of drug mixtures. Biometrics 1969; 25: 477-87.
42. Plackett RL, Hewlett PS. Quantal responses to mixtures of poisons. J R Stat Soc Series B Stat Methodol 1952; 14: 141-63.
43. Cox DR. The analysis of multivariate binary data. Applied Statistics 1972; 21: 113-20.
44. Gennings C, Carter Jr WH, Campbell ED, Staniswalis JG, Martin TJ, Martin BR, et al. Isobolographic characterization of drug interactions incorporating biological variability. J Pharmacol Exp Ther 1990; 252: 208.
45. Chou TC, Hayball M. CalcuSyn for Windows: Multiple-Drug Dose-Effect Anayzer and Manual. Cambridge, United Kingdom, Biosoft, Cambridge Place. 1996.
46. Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach. 2nd ed. New York, ASA. 2002, pp 1-488.
47. Weakliem DL. Introduction to the special issue on model selection. Sociol Methods Res 2004; 33: 167.
48. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-23.
49. Schwarz G. Estimating the dimension of a model. Ann Stat 1978; 6: 461-4.
50. Reschenhofer E. Prediction with vague prior knowledge. Commun Stat Theory Methods 1996; 25: 601-8.
51. Kullback S. The kullback-leibler distance. Am Stat 1987; 41: 340-1.
52. Kullback S, Leibler RA. On information and sufficiency. Ann Math Statist 1951; 22: 79-86.
53. Babyak MA. What you see may not be what you get : a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004; 66: 411-21.
54. Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. background, goals, and general strategy. J Clin Epidemiol 1995; 48: 1495-501. (Pubitemid 26035532)
55. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48: 1503-10.
56. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-9.
57. Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res 2004; 33: 261.